{"database": "lobbying", "table": "lobbying_activities", "rows": [[659474, "5c8a808a-dfb4-4a29-a7a7-40b967c85a1f", "Q3", "BGR GOVERNMENT AFFAIRS", 5357, "ELI LILLY & CO INC", 2008, "third_quarter", "HCR", "Dual-eligible Medicare program participants; Prescription mental health medications; Patient safety legislation; Patent reform Medicare Part-D non-interference legislation; FDARA; PDUFA; Medicaid rebates; Follow-on biologics.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2008-09-15T17:49:03-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["659474"], "units": {}, "query_ms": 0.6143751088529825, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}